Literature DB >> 17559942

No association between the tumor necrosis factor-alpha gene promoter polymorphisms and schizophrenia in a Japanese population.

Yuichiro Watanabe1, Tatsuyuki Muratake, Naoshi Kaneko, Naoki Fukui, Yasushi Nara, Toshiyuki Someya.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is a pleiotrophic cytokine and exerts neuroprotective and neurodegenerative effects in brain. Several studies have indicated that TNF-alpha is likely related to the pathogenesis of schizophrenia. Recent genetic investigations have revealed that a TNF-alpha gene promoter polymorphism (-G308A) is associated with schizophrenia, although negative findings have also been reported. To assess whether the TNF-alpha gene promoter variants including -G308A could be implicated in vulnerability to schizophrenia, we conducted a case-control association analysis (265 cases and 424 controls) and the transmission disequilibrium test (TDT) analysis (83 trios) for four polymorphisms (-G238A, -G308A, -C857T and -T1031C) in Japanese subjects. In a case-control analysis, there was no significant association between the promoter polymorphisms or haplotypes in the TNF-alpha gene and schizophrenia. In the TDT analysis, we also did not observe transmission distortion. Our results suggest that the above four polymorphisms in the promoter region of the TNF-alpha gene appear not to confer increased susceptibility for schizophrenia in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559942     DOI: 10.1016/j.psychres.2006.03.009

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

2.  Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia.

Authors:  Lekshmy Srinivas; Neetha N Vellichirammal; Ann Mary Alex; Chandrasekharan Nair; Indu V Nair; Moinak Banerjee
Journal:  J Neuroinflammation       Date:  2016-05-13       Impact factor: 8.322

3.  The reduction of CSF tumor necrosis factor alpha levels in schizophrenia: no correlations with psychopathology and coincident metabolic characteristics.

Authors:  Haibing Zhu; Danfeng Wang; Xiuqin Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-03       Impact factor: 2.570

4.  Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia.

Authors:  Saeed Kadasah; Misbahul Arfin; Sadaf Rizvi; Mohammed Al-Asmari; Abdulrahman Al-Asmari
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-12       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.